Literature DB >> 30653055

Renin as a Marker of Tissue-Perfusion and Prognosis in Critically Ill Patients.

Patrick J Gleeson, Ilaria Alice Crippa1, Wasineenart Mongkolpun1, Federica Zama Cavicchi1, Tess Van Meerhaeghe1, Serge Brimioulle1,2, Fabio Silvio Taccone1,2, Jean-Louis Vincent1,2, Jacques Creteur1,2.   

Abstract

OBJECTIVES: To characterize renin in critically ill patients. Renin is fundamental to circulatory homeostasis and could be a useful marker of tissue-perfusion. However, diurnal variation, continuous renal replacement therapy and drug-interference could confound its use in critical care practice.
DESIGN: Prospective observational study.
SETTING: Single-center, mixed medical-surgical ICU in Europe. PATIENTS: Patients over 18 years old with a baseline estimated glomerular filtration rate greater than 30 mL/min/1.73 m and anticipated ICU stay greater than 24 hours. Informed consent was obtained from the patient or next-of-kin.
INTERVENTIONS: Direct plasma renin was measured in samples drawn 6-hourly from arterial catheters in recumbent patients and from extracorporeal continuous renal replacement therapy circuits. Physiologic variables and use of drugs that act on the renin-angiotensin-aldosterone system were recorded prospectively. Routine lactate measurements were used for comparison.
MEASUREMENTS AND MAIN RESULTS: One-hundred twelve arterial samples (n = 112) were drawn from 20 patients (65% male; mean ± SD, 60 ± 14 yr old) with septic shock (30%), hemorrhagic shock (15%), cardiogenic shock (20%), or no circulatory shock (35%). The ICU mortality rate was 30%. Renin correlated significantly with urine output (repeated-measures correlation coefficient = -0.29; p = 0.015) and mean arterial blood pressure (repeated-measures correlation coefficient = -0.35; p < 0.001). There was no diurnal variation of renin or significant interaction of renin-angiotensin-aldosterone system drugs with renin in this population. Continuous renal replacement therapy renin removal was negligible (mass clearance ± SD 4% ± 4.3%). There was a significant difference in the rate of change of renin over time between survivors and nonsurvivors (-32 ± 26 μU/timepoint vs +92 ± 57 μU/timepoint p = 0.03; mean ± SEM), but not for lactate (-0.14 ± 0.04 mM/timepoint vs +0.15 ± 0.21 mM/timepoint; p = 0.07). Maximum renin achieved significant prognostic value for ICU mortality (receiver operator curve area under the curve 0.80; p = 0.04), whereas maximum lactate did not (receiver operator curve area under the curve, 0.70; p = 0.17).
CONCLUSIONS: In an heterogeneous ICU population, renin measurement was not significantly affected by diurnal variation, continuous renal replacement therapy, or drugs. Renin served as a marker of tissue-perfusion and outperformed lactate as a predictor of ICU mortality.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30653055     DOI: 10.1097/CCM.0000000000003544

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  12 in total

1.  Renin signals renal hypoperfusion during Parkland fluid resuscitation of severe burns - a prospective longitudinal cohort study.

Authors:  Rosa Vieweg; Mikael Järemo; Ingrid Steinvall; Moustafa Elmasry; Islam Abdelrahman; Folke Sjöberg
Journal:  Int J Burns Trauma       Date:  2020-12-15

2.  COVID-19, ACE2, and the cardiovascular consequences.

Authors:  Andrew M South; Debra I Diz; Mark C Chappell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-03-31       Impact factor: 4.733

Review 3.  Vasopressor Choice and Timing in Vasodilatory Shock.

Authors:  Patrick M Wieruszewski; Ashish K Khanna
Journal:  Crit Care       Date:  2022-03-22       Impact factor: 9.097

4.  Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock. A Clinical Trial.

Authors:  Rinaldo Bellomo; Lui G Forni; Laurence W Busse; Michael T McCurdy; Kealy R Ham; David W Boldt; Johanna Hästbacka; Ashish K Khanna; Timothy E Albertson; James Tumlin; Kristine Storey; Damian Handisides; George F Tidmarsh; Lakhmir S Chawla; Marlies Ostermann
Journal:  Am J Respir Crit Care Med       Date:  2020-11-01       Impact factor: 21.405

5.  Serum renin and major adverse kidney events in critically ill patients: a multicenter prospective study.

Authors:  Alexander H Flannery; Victor Ortiz-Soriano; Xilong Li; Fabiola G Gianella; Robert D Toto; Orson W Moe; Prasad Devarajan; Stuart L Goldstein; Javier A Neyra
Journal:  Crit Care       Date:  2021-08-14       Impact factor: 9.097

6.  Why the renin-angiotensin-aldosterone system (RAAS) in critically ill patients can no longer be ignored.

Authors:  Alexander Zarbock; Lakhmir Chawla; Rinaldo Bellomo
Journal:  Crit Care       Date:  2021-11-14       Impact factor: 9.097

Review 7.  The Renin-Angiotensin System as a Component of Biotrauma in Acute Respiratory Distress Syndrome.

Authors:  Katharina Krenn; Verena Tretter; Felix Kraft; Roman Ullrich
Journal:  Front Physiol       Date:  2022-04-13       Impact factor: 4.755

8.  Impaired angiotensin II type 1 receptor signaling contributes to sepsis-induced acute kidney injury.

Authors:  Daniel E Leisman; Tiago D Fernandes; Vanesa Bijol; Mabel N Abraham; Jake R Lehman; Matthew D Taylor; Christine Capone; Omar Yaipan; Rinaldo Bellomo; Clifford S Deutschman
Journal:  Kidney Int       Date:  2020-08-31       Impact factor: 10.612

9.  Angiotensin II for the Treatment of COVID-19-Related Vasodilatory Shock.

Authors:  Jonathan H Chow; Michael A Mazzeffi; Michael T McCurdy
Journal:  Anesth Analg       Date:  2020-07       Impact factor: 5.108

10.  Alveolar, Endothelial, and Organ Injury Marker Dynamics in Severe COVID-19.

Authors:  Daniel E Leisman; Arnav Mehta; B Taylor Thompson; Nicole C Charland; Anna L K Gonye; Irena Gushterova; Kyle R Kays; Hargun K Khanna; Thomas J LaSalle; Kendall M Lavin-Parsons; Brendan M Lilley; Carl L Lodenstein; Kasidet Manakongtreecheep; Justin D Margolin; Brenna N McKaig; Maricarmen Rojas-Lopez; Brian C Russo; Nihaarika Sharma; Jessica Tantivit; Molly F Thomas; Blair Alden Parry; Alexandra-Chloé Villani; Moshe Sade-Feldman; Nir Hacohen; Michael R Filbin; Marcia B Goldberg
Journal:  Am J Respir Crit Care Med       Date:  2022-03-01       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.